Differential expression and pathway analyses indicated that PC19-PF is marked by persistent TGF-β1-driven fibrotic and immune pathways, whereas IPF showed elevated BMP signaling, which appears to inhibit TGF-β1 signaling [83]. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.